Arcadia Biosciences Inc Revenue Growth Rates (RKDA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Arcadia Biosciences Inc   (NASDAQ: RKDA)
    Sector • Energy    Industry • Oil And Gas Production
   Industry • Oil And Gas Production
   Sector • Energy
 

RKDA's Revenue Growth by Quarter and Year

Arcadia Biosciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RKDA/growth
https://api.csimarket.com/api/v1/companies/RKDA/fundamentals
https://api.csimarket.com/api/v1/companies/RKDA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
RKDA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.62
2nd Quarter June 1.44
1st Quarter March 1.10
FY 4.16

RKDAs Annual Revenue
Arcadia Biosciences Inc 's Revenue in the fiscal year 2025 $ 4.86 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2024 $ 5.05 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2023 $ 5.33 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2022 $ 9.96 millions
Arcadia Biosciences Inc 's Revenue in the fiscal year 2021 $ 6.78 millions




RKDA Revenue third quarter 2026 Y/Y Growth Comment
Arcadia Biosciences Inc reported Revenue improvement of 24.54% year on year in the third quarter 2026, to $ 1.62 millions, this is lower than Arcadia Biosciences Inc 's recent average Revenue rise of 59.46%.

Looking into third quarter 2026 results within Oil And Gas Production industry 60 other companies have achieved higher Revenue growth. While Arcadia Biosciences Inc ' s Revenue rise of 24.54% ranks overall at the positon no. 2913 in the third quarter 2026.


RKDA Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 24.54 %
2nd Quarter June -1.37 %
1st Quarter March -8.33 %
FY   -

Financial Statements
Arcadia Biosciences Inc 's third quarter 2026 Revenue $ 1.62 millions RKDA's Income Statement
Arcadia Biosciences Inc 's third quarter 2025 Revenue $ 1.30 millions Quarterly RKDA's Income Statement


RKDA Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.43 %
2nd Quarter June 30.91 %
1st Quarter March 22.22 %
FY (Year on Year)   -


Back to RKDA Growth rate Comparisons >> Back to RKDA Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry #61
Energy Sector #89
Overall #2913

Revenue Y/Y Growth Statistics
High Average Low
1613.94 % 59.46 % -78.98 %
(Sep 30 2021)   (Dec 31 2018)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry #61
Energy Sector #89
Overall #2913
Revenue Y/Y Growth Statistics
High Average Low
1613.94 % 59.46 % -78.98 %
(Sep 30 2021)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Arcadia Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2170.7 % 51.99 % -88.39 %
(Dec 31 2020)  


RKDA's III. Quarter Q/Q Revenue Comment
Arcadia Biosciences Inc achieved in the III. Quarter 2026 below company average Revenue rise of 12.43% quarter on quarter, to $ 1.62 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -10.96% growth in the III. Quarter a year ago

Within Oil And Gas Production industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Arcadia Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 733.


Revenue Q/Q Growth Company Ranking
Within: No.
Oil And Gas Production Industry #43
Energy Sector #49
Overall #733
Revenue Q/Q Growth Company Ranking
Within: No.
Oil And Gas Production Industry #43
Energy Sector #49
Overall #733
Revenue Q/Q Growth Statistics
High Average Low
2170.7 % 51.99 % -88.39 %
(Dec 31 2020)  


RKDA's III. Quarter Q/Q Revenue Comment
Arcadia Biosciences Inc achieved in the III. Quarter 2026 below company average Revenue rise of 12.43% quarter on quarter, to $ 1.62 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -10.96% in the III. Quarter a year ago.

Within Oil And Gas Production industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Arcadia Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 733.


Arcadia Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 5.06
Y / Y Revenue Growth (TTM) 3.24 %
Year on Year Revenue Growth Overall Ranking # 2296
Seqeuential Revenue Change (TTM) 6.68 %
Seq. Revenue Growth (TTM) Overall Ranking # 2291


Cumulative Revenue growth Comment
Although Arcadia Biosciences Inc 's Annual Revenue growth year on year were below company's average 42.98% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.24% year on year, from -7.65% in Jun 30 2026.

In the Energy sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2296, from total ranking in previous quarter at 2489.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry # 39
Energy Sector # 50
Overall # 2296

Revenue TTM Y/Y Growth Statistics
High Average Low
789.32 %
 42.98 %
-63.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 50
S&P 500 # 2291
Cumulative Revenue growth Comment
Although Arcadia Biosciences Inc 's Annual Revenue growth year on year were below company's average 42.98% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.24% year on year, from -7.65% in Jun 30 2026.

In the Energy sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2296, from total ranking in previous quarter at 2489.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Oil And Gas Production Industry # 39
Energy Sector # 50
Overall # 2296

Revenue TTM Y/Y Growth Statistics
High Average Low
789.32 %
42.98 %
-63.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 50
S&P 500 # 2291




Other Revenue Growth
Oil And Gas Production Industry Revenue Growth Trends and Statistics
Energy Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RKDA's Revenue Growth Ratio versus Oil And Gas Production Industry, Energy Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Energy SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Global Partners Lp42.39%$ 42.390 millions
World Kinect Corporation41.30%$ 41.301 millions
Natural Gas Services Group Inc 41.14%$ 41.140 millions
Diamondback Energy Inc 38.40%$ 38.405 millions
Landbridge Company Llc38.27%$ 38.271 millions
Martin Midstream Partners L p 37.35%$ 37.347 millions
Sandridge Energy Inc 36.65%$ 36.648 millions
Chevron Corp36.34%$ 36.343 millions
Highpeak Energy Inc 35.98%$ 35.983 millions
Texas Pacific Land Corporation34.62%$ 34.619 millions
Exxon Mobil Corporation32.68%$ 32.675 millions
Talos Energy Inc 32.43%$ 32.427 millions
Imperial Oil Limited32.41%$ 32.409 millions
Kosmos Energy Ltd 31.87%$ 31.869 millions
Ring Energy Inc 30.21%$ 30.206 millions
Chord Energy Corporation29.81%$ 29.814 millions
Conocophillips29.30%$ 29.299 millions
Granite Ridge Resources Inc 29.06%$ 29.063 millions
Antero Resources Corporation28.74%$ 28.735 millions
Select Water Solutions inc 28.26%$ 28.255 millions
Arko Petroleum Corp 27.28%$ 27.283 millions
Profrac Holding Corp 26.79%$ 26.792 millions
W and t Offshore inc 26.39%$ 26.387 millions
Ranger Energy Services inc 26.30%$ 26.299 millions
Liberty Energy Inc 26.26%$ 26.257 millions
Ovintiv Inc 25.94%$ 25.944 millions
Arcadia Biosciences Inc 24.35%$ 24.347 millions
Ramaco Resources Inc 24.04%$ 24.045 millions
Matador Resources Company23.82%$ 23.815 millions
Vitesse Energy Inc 23.00%$ 22.996 millions


About Arcadia Biosciences Inc Revenue Growth Rates (RKDA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Arcadia Biosciences Inc (CIK 1469443).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-349205
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Arcadia Biosciences Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.